This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (non-eHealth) (304) Spinal Cord Injury Rehabilitation (62)

Published on in Vol 7, No 3 (2018): March

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/8655, first published .
Treatment with Creatine Monohydrate in Spinal and Bulbar Muscular Atrophy: Protocol for a Randomized, Double-Blind, Placebo-Controlled Trial

Treatment with Creatine Monohydrate in Spinal and Bulbar Muscular Atrophy: Protocol for a Randomized, Double-Blind, Placebo-Controlled Trial

Treatment with Creatine Monohydrate in Spinal and Bulbar Muscular Atrophy: Protocol for a Randomized, Double-Blind, Placebo-Controlled Trial

Authors of this article:

Yasuhiro Hijikata1 Author Orcid Image ;   Masahisa Katsuno1 Author Orcid Image ;   Keisuke Suzuki1, 2 Author Orcid Image ;   Atsushi Hashizume1 Author Orcid Image ;   Amane Araki1 Author Orcid Image ;   Shinichiro Yamada1 Author Orcid Image ;   Tomonori Inagaki1 Author Orcid Image ;   Daisuke Ito1 Author Orcid Image ;   Akihiro Hirakawa3 Author Orcid Image ;   Fumie Kinoshita3 Author Orcid Image ;   Masahiko Gosho4 Author Orcid Image ;   Gen Sobue1, 5 Author Orcid Image
Article Authors Cited by (8) Tweetations (1) Metrics

Journals

  1. Mitsumoto H, Chiuzan C, Gilmore M, Zhang Y, Simmons Z, Paganoni S, Kisanuki Y, Zinman L, Jawdat O, Sorenson E, Floeter M, Pioro E, Fernandes Filho J, Heitzman D, Fournier C, Oskarsson B, Heiman‐Patterson T, Maragakis N, Joyce N, Hayat G, Nations S, Scelsa S, Walk D, Elman L, Hupf J, McHale B. Primary lateral sclerosis (PLS) functional rating scale: PLS‐specific clinimetric scale. Muscle & Nerve 2020;61(2):163 View
  2. Malek E, Salameh J, Makki A. Kennedy’s disease: an under-recognized motor neuron disorder. Acta Neurologica Belgica 2020;120(6):1289 View
  3. Arnold F, Merry D. Molecular Mechanisms and Therapeutics for SBMA/Kennedy's Disease. Neurotherapeutics 2019;16(4):928 View
  4. Querin G, Bede P, Marchand-Pauvert V, Pradat P. Biomarkers of Spinal and Bulbar Muscle Atrophy (SBMA): A Comprehensive Review. Frontiers in Neurology 2018;9 View
  5. Kreider R, Stout J. Creatine in Health and Disease. Nutrients 2021;13(2):447 View
  6. Inagaki T, Hashizume A, Hijikata Y, Yamada S, Ito D, Kishimoto Y, Torii R, Sato H, Hirakawa A, Katsuno M. Development of a functional composite for the evaluation of spinal and bulbar muscular atrophy. Scientific Reports 2022;12(1) View
  7. Torii R, Hashizume A, Yamada S, Ito D, Kishimoto Y, Moriyoshi H, Inagaki T, Nakamura R, Nakamura T, Naoi T, Morita M, Katsuno M. Clinical Features of Female Carriers and Prodromal Male Patients With Spinal and Bulbar Muscular Atrophy. Neurology 2023;100(1) View
  8. Tsvetkova D, Kostadinova I, Landzhov B, Vezenkov L, Marinov L, Ivanova I. Application of DPPH assay for the evaluation of the antiradical activity of Creatine Lysinate. Journal of Advanced Pharmacy Education and Research 2023;13(1):162 View